Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1428 |
|---|---|
| Identifier | NCT05057273 |
| Trial Title | Safety and Efficacy of Oral BT-11 in Crohn's Disease Patients With Moderate to Severe Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: BT-11|DRUG: Active comparator |
Participant Information
| Sponsor | NImmune Biopharma |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2021-11 |
|---|---|
| Primary Completion Date | 2022-02 |
| Completion Date | 2022-02 |